| Tamara Samardzic, MD | |
|
20 York St, New Haven, CT 06510 | |
| (203) 688-4242 | |
| Not Available |
| Full Name | Tamara Samardzic |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 11 Years |
| Location | 20 York St, New Haven, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235629320 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 67446 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Yale-new Haven Hospital | New haven, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northeast Medical Group Inc | 1254233836 | 1251 |
News Archive
BioTime, Inc., a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that two human embryonic stem (hES) cell lines, ESI-014 and ESI-017, developed by a BioTime subsidiary have been approved by the National Institutes of Health (NIH) for inclusion in the NIH Human Embryonic Stem Cell Registry.
Hawaii Pacific Health, Saint Barnabas Health Care System N.J., and XCelience LLC, have received CEO Cancer Gold Standard™ accreditation, recognizing the commitment of these organizations to reducing the risk of cancer for employees and their families by promoting healthy lifestyle choices, encouraging early detection through cancer screenings, and ensuring access to quality treatment.
Enrollment in the private plans is projected to increase 11 percent next year, while premiums hold steady, officials say, disproving predictions made by critics of the health care law.
Individuals with post-traumatic stress disorder (PTSD) relive past traumas again and again, bound in a virtual prison of their memories.
› Verified 5 days ago
| Entity Name | Northeast Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043278351 PECOS PAC ID: 1254233836 Enrollment ID: O20040123000522 |
News Archive
BioTime, Inc., a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that two human embryonic stem (hES) cell lines, ESI-014 and ESI-017, developed by a BioTime subsidiary have been approved by the National Institutes of Health (NIH) for inclusion in the NIH Human Embryonic Stem Cell Registry.
Hawaii Pacific Health, Saint Barnabas Health Care System N.J., and XCelience LLC, have received CEO Cancer Gold Standard™ accreditation, recognizing the commitment of these organizations to reducing the risk of cancer for employees and their families by promoting healthy lifestyle choices, encouraging early detection through cancer screenings, and ensuring access to quality treatment.
Enrollment in the private plans is projected to increase 11 percent next year, while premiums hold steady, officials say, disproving predictions made by critics of the health care law.
Individuals with post-traumatic stress disorder (PTSD) relive past traumas again and again, bound in a virtual prison of their memories.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tamara Samardzic, MD 20 York St, Cb-329, New Haven, CT 06510-3220 Ph: (203) 688-4847 | Tamara Samardzic, MD 20 York St, New Haven, CT 06510 Ph: (203) 688-4242 |
News Archive
BioTime, Inc., a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that two human embryonic stem (hES) cell lines, ESI-014 and ESI-017, developed by a BioTime subsidiary have been approved by the National Institutes of Health (NIH) for inclusion in the NIH Human Embryonic Stem Cell Registry.
Hawaii Pacific Health, Saint Barnabas Health Care System N.J., and XCelience LLC, have received CEO Cancer Gold Standard™ accreditation, recognizing the commitment of these organizations to reducing the risk of cancer for employees and their families by promoting healthy lifestyle choices, encouraging early detection through cancer screenings, and ensuring access to quality treatment.
Enrollment in the private plans is projected to increase 11 percent next year, while premiums hold steady, officials say, disproving predictions made by critics of the health care law.
Individuals with post-traumatic stress disorder (PTSD) relive past traumas again and again, bound in a virtual prison of their memories.
› Verified 5 days ago
Alexander B Pine, MD, PHD Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 20 York St, Cb-2041, New Haven, CT 06510 Phone: 203-688-4748 Fax: 203-688-4740 | |
Alina Rakhuba, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 20 York Street, Cb-2041, New Haven, CT 06510 Phone: 203-688-4748 Fax: 203-688-4740 | |
Omar Yasser Abed Shakhtour, MBBS Hospitalist Medicare: Medicare Enrolled Practice Location: 20 York Street, Cb-2041, New Haven, CT 06510 Phone: 036-884-7482 Fax: 036-884-7402 | |
Dr. Deepti Canchi, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-688-4748 Fax: 203-688-4740 | |
Christina Nefeli Dimopoulos, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-688-4242 | |
Dr. Nidhi Shah, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 20 York Street, Cb-2041, New Haven, CT 06510 Phone: 203-688-4748 Fax: 203-688-4740 | |
Dr. Rupert Dogbey, MBCHB Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1450 Chapel St, New Haven, CT 06511 Phone: 203-789-3034 |